Article Details
Retrieved on: 2021-02-09 16:43:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
July 2020 saw R-Pharm sign a licensing deal with AstraZeneca to produce and distribute doses of its adenovirus-based COVID-19 shot. Under that ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here